ABIMMUNE BIOPHARMA - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
88120156
Word Mark
ABIMMUNE BIOPHARMA
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2020-06-08
Filing Date
2018-09-17
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-08-27
Attorney Name
Law Office Assigned Location Code
N30
Employee Name
DANG, PETER T
Statements
Disclaimer with Predetermined Text
"BIOPHARMA"
Goods and Services
Custom manufacture of proteins and antibodies by pharmaceutical compounders
Classification Information
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2018-09-23
Primary Code
040
Correspondences
Name
Abraham Lichy
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-09-20 | NEW APPLICATION ENTERED IN TRAM |
2018-09-23 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-12-27 | ASSIGNED TO EXAMINER |
2019-01-02 | NON-FINAL ACTION WRITTEN |
2019-01-02 | NON-FINAL ACTION E-MAILED |
2019-01-02 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-07-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-07-01 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-07-05 | ASSIGNED TO LIE |
2019-07-12 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-07-12 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-07-19 | EXAMINERS AMENDMENT -WRITTEN |
2019-07-19 | EXAMINERS AMENDMENT E-MAILED |
2019-07-19 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2019-07-19 | EXAMINER'S AMENDMENT ENTERED |
2019-07-19 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-08-07 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-08-27 | PUBLISHED FOR OPPOSITION |
2019-08-27 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-10-22 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-06-08 | ABANDONMENT - NO USE STATEMENT FILED |
2020-06-08 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |